Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1021/acsinfecdis.0c00236 http://scihub22266oqcxt.onion/10.1021/acsinfecdis.0c00236 32485102!ä!32485102 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       ACS+Infect+Dis 2020 ; 6 (7): 1624-1634 Nephropedia Template TP {{tp|p=32485102|t=2020. Current Perspective of Antiviral Strategies against COVID-19 |pdf=|usr=}}{{32485102}} gab.com Text Current Perspective of Antiviral Strategies against COVID-19 JO: ACS Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32485102 #FOAvip COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020. This novel coronavirus disease, caused by the SARS-CoV-2 virus, has resulted in severe and unprecedented social and economic disruptions globally. Since the discovery of COVID-19 in December 2019, numerous antivirals have been tested for efficacy against SARS-CoV-2 in vitro and also clinically to treat this disease. This review article discusses the main antiviral strategies currently employed and summarizes reported in vitro and in vivo efficacies of key antiviral compounds in use. Twit Text FOAVip Current Perspective of Antiviral Strategies against COVID-19 ????ACS Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32485102 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32485102 #FOAvip English Wikipedia <ref>{{Cite pmid|32485102}}</ref> Current Perspective of Antiviral Strategies against COVID-19 #MMPMID32485102 Ahidjo BA; Loe MWC; Ng YL; Mok CK; Chu JJH ACS Infect Dis 2020[Jul]; 6 (7): 1624-1634 PMID32485102show ga COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020. This novel coronavirus disease, caused by the SARS-CoV-2 virus, has resulted in severe and unprecedented social and economic disruptions globally. Since the discovery of COVID-19 in December 2019, numerous antivirals have been tested for efficacy against SARS-CoV-2 in vitro and also clinically to treat this disease. This review article discusses the main antiviral strategies currently employed and summarizes reported in vitro and in vivo efficacies of key antiviral compounds in use. |Animals[MESH] |Antiviral Agents/pharmacology/*therapeutic use[MESH] |BCG Vaccine/therapeutic use[MESH] |Betacoronavirus/chemistry/*physiology[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Coronavirus Infections/*drug therapy/physiopathology/virology[MESH] |Drug Repositioning[MESH] |Host-Pathogen Interactions/drug effects/immunology[MESH] |Humans[MESH] |Immunologic Factors/therapeutic use[MESH] |Inhibitory Concentration 50[MESH] |Measles-Mumps-Rubella Vaccine/therapeutic use[MESH] |Mice[MESH] |Pandemics[MESH] |Pneumonia, Viral/*drug therapy/physiopathology/virology[MESH] |SARS-CoV-2[MESH] |Treatment Outcome[MESH]Current Perspective of Antiviral Strategies against COVID-19 (epmc).pdf DeepDyve Pubget Overpricing